These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1290 related items for PubMed ID: 26975630

  • 1. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
    Peng YY, He YH, Chen C, Xu T, Li L, Ni MM, Meng XM, Huang C, Li J.
    Cancer Lett; 2016 Jun 28; 376(1):10-21. PubMed ID: 26975630
    [Abstract] [Full Text] [Related]

  • 2. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y, Jiang L, Hu Y, Xiao C, Xu N, Zhou J, Zhou X.
    BMC Cancer; 2017 Feb 28; 17(1):161. PubMed ID: 28241806
    [Abstract] [Full Text] [Related]

  • 3. NLRC5 mediates cell proliferation, migration, and invasion by regulating the Wnt/β-catenin signalling pathway in clear cell renal cell carcinoma.
    Wang Q, Ding H, He Y, Li X, Cheng Y, Xu Q, Yang Y, Liao G, Meng X, Huang C, Li J.
    Cancer Lett; 2019 Mar 01; 444():9-19. PubMed ID: 30543814
    [Abstract] [Full Text] [Related]

  • 4. UNC119 promotes the growth and migration of hepatocellular carcinoma via Wnt/β/catenin and TGF/β-EMT signaling pathways.
    Liu Z, Zhang Y, Xu Z.
    J BUON; 2018 Mar 01; 23(1):188-192. PubMed ID: 29552782
    [Abstract] [Full Text] [Related]

  • 5. CUL4B activates Wnt/β-catenin signalling in hepatocellular carcinoma by repressing Wnt antagonists.
    Yuan J, Han B, Hu H, Qian Y, Liu Z, Wei Z, Liang X, Jiang B, Shao C, Gong Y.
    J Pathol; 2015 Apr 01; 235(5):784-95. PubMed ID: 25430888
    [Abstract] [Full Text] [Related]

  • 6. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L, Wang X, Jia T, Wei W, Chua MS, So S.
    Oncotarget; 2015 Sep 22; 6(28):25390-401. PubMed ID: 26246473
    [Abstract] [Full Text] [Related]

  • 7. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
    Tsao CM, Yan MD, Shih YL, Yu PN, Kuo CC, Lin WC, Li HJ, Lin YW.
    Hepatology; 2012 Dec 22; 56(6):2277-87. PubMed ID: 22767186
    [Abstract] [Full Text] [Related]

  • 8. Down-regulated FSTL5 promotes cell proliferation and survival by affecting Wnt/β-catenin signaling in hepatocellular carcinoma.
    Zhang D, Ma X, Sun W, Cui P, Lu Z.
    Int J Clin Exp Pathol; 2015 Dec 22; 8(3):3386-94. PubMed ID: 26045876
    [Abstract] [Full Text] [Related]

  • 9. P7TP3 inhibits tumor development, migration, invasion and adhesion of liver cancer through the Wnt/β-catenin signaling pathway.
    Zhao J, Wang Y, Han M, Lu H, Chen X, Liu S, Yuan X, Han K, Liang P, Cheng J.
    Cancer Sci; 2020 Mar 22; 111(3):994-1007. PubMed ID: 31746531
    [Abstract] [Full Text] [Related]

  • 10. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
    Zhang S, Zhang F, Chen Q, Wan C, Xiong J, Xu J.
    J Exp Clin Cancer Res; 2019 Nov 14; 38(1):467. PubMed ID: 31727171
    [Abstract] [Full Text] [Related]

  • 11. miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway.
    Gu W, Li X, Wang J.
    Oncol Rep; 2014 Jan 14; 31(1):397-404. PubMed ID: 24190507
    [Abstract] [Full Text] [Related]

  • 12. UNC119 promoted cell growth and migration by Wnt/β-catenin signal and TGF-β/EMT signal pathway in hepatocellular carcinoma.
    Liu ZH, Zhang YF, Xu ZD, Z H L, Y F Z, Z D X.
    J BUON; 2018 Jan 14; 23(6):1717-1724. PubMed ID: 30610799
    [Abstract] [Full Text] [Related]

  • 13. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
    Zhang N, Chen X.
    Cell Oncol (Dordr); 2020 Feb 14; 43(1):137-153. PubMed ID: 31691159
    [Abstract] [Full Text] [Related]

  • 14. Downregulation of miR-432 activates Wnt/β-catenin signaling and promotes human hepatocellular carcinoma proliferation.
    Jiang N, Chen WJ, Zhang JW, Xu C, Zeng XC, Zhang T, Li Y, Wang GY.
    Oncotarget; 2015 Apr 10; 6(10):7866-79. PubMed ID: 25797263
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M, Zhang XY, Yu X.
    Biomed Pharmacother; 2017 Jan 10; 85():348-354. PubMed ID: 27899259
    [Abstract] [Full Text] [Related]

  • 17. The effect of cell cycle and expression of cyclin B1 and cyclin C protein in hepatocellular carcinoma cell line HepG2 and SMMC-7721 after of silencing β-catenin gene.
    Wang B, Xunsun, Liu JY, Yang D, Yang LL, Kong DX, Meng XW.
    Hepatogastroenterology; 2012 Jan 10; 59(114):515-8. PubMed ID: 22024040
    [Abstract] [Full Text] [Related]

  • 18. KIF2C: a novel link between Wnt/β-catenin and mTORC1 signaling in the pathogenesis of hepatocellular carcinoma.
    Wei S, Dai M, Zhang C, Teng K, Wang F, Li H, Sun W, Feng Z, Kang T, Guan X, Xu R, Cai M, Xie D.
    Protein Cell; 2021 Oct 10; 12(10):788-809. PubMed ID: 32748349
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of MUC13, a Poor Prognostic Predictor, Promotes Cell Growth by Activating Wnt Signaling in Hepatocellular Carcinoma.
    Dai Y, Liu L, Zeng T, Liang JZ, Song Y, Chen K, Li Y, Chen L, Zhu YH, Li J, Li Y, Xie D, Yuan YF, Guan XY.
    Am J Pathol; 2018 Feb 10; 188(2):378-391. PubMed ID: 29174628
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 65.